SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-16-000028
Filing Date
2016-05-13
Accepted
2016-05-13 07:23:42
Documents
3
Period of Report
2016-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axovant-xform8xk.htm 8-K 29334
2 EXHIBIT 99.1 ex991.htm EX-99.1 6882
3 axovantlogo.jpg GRAPHIC 4155
  Complete submission text file 0001636050-16-000028.txt   43540
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 161645864
SIC: 2834 Pharmaceutical Preparations